[HTML][HTML] Renoprotective effects of mangiferin: pharmacological advances and future perspectives
Both acute and chronic kidney diseases substantially contribute to the morbidities and
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
[HTML][HTML] Renoprotective Effects of Mangiferin: Pharmacological Advances and Future Perspectives
S Akter, A Moni, GM Faisal, MR Uddin… - … Research and Public …, 2022 - ncbi.nlm.nih.gov
Both acute and chronic kidney diseases substantially contribute to the morbidities and
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
Renoprotective Effects of Mangiferin: Pharmacological Advances and Future Perspectives
S Akter, A Moni, GM Faisal… - … and public health, 2022 - pubmed.ncbi.nlm.nih.gov
Both acute and chronic kidney diseases substantially contribute to the morbidities and
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
Renoprotective Effects of Mangiferin: Pharmacological Advances and Future Perspectives.
S Akter, A Moni, GM Faisal, MR Uddin… - … Research and Public …, 2022 - europepmc.org
Both acute and chronic kidney diseases substantially contribute to the morbidities and
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
Renoprotective Effects of Mangiferin: Pharmacological Advances and Future Perspectives
S Akter, A Moni, GM Faisal, MR Uddin, N Jahan… - IJERPH, 2022 - econpapers.repec.org
Both acute and chronic kidney diseases substantially contribute to the morbidities and
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
Renoprotective Effects of Mangiferin: Pharmacological Advances and Future Perspectives
S Akter, A Moni, GM Faisal, MR Uddin… - … and Public Health, 2022 - search.proquest.com
Both acute and chronic kidney diseases substantially contribute to the morbidities and
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
[PDF][PDF] Renoprotective Effects of Mangiferin: Pharmacological Advances and Future Perspectives
S Akter, A Moni, GM Faisal, MR Uddin… - Int. J. Environ. Res …, 2022 - academia.edu
Both acute and chronic kidney diseases substantially contribute to the morbidities and
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
Renoprotective Effects of Mangiferin: Pharmacological Advances and Future Perspectives
S Akter, A Moni, GM Faisal, MR Uddin… - International Journal of …, 2022 - cir.nii.ac.jp
抄録< jats: p> Both acute and chronic kidney diseases substantially contribute to the
morbidities and mortality of patients worldwide. The existing therapeutics, which are mostly …
morbidities and mortality of patients worldwide. The existing therapeutics, which are mostly …
[PDF][PDF] Renoprotective Effects of Mangiferin: Pharmacological Advances and Future Perspectives
S Akter, A Moni, GM Faisal, MR Uddin… - Int. J. Environ. Res …, 2022 - researchgate.net
Both acute and chronic kidney diseases substantially contribute to the morbidities and
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
Renoprotective Effects of Mangiferin: Pharmacological Advances and Future Perspectives
S Akter, A Moni, GM Faisal, MR Uddin, N Jahan… - IJERPH, 2022 - ideas.repec.org
Both acute and chronic kidney diseases substantially contribute to the morbidities and
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …
mortality of patients worldwide. The existing therapeutics, which are mostly developed from …